Success Story: Thanks To Our Expert Guidance, NIW Approved Without RFE For A Chemical Engineering Researcher From China

 

Client’s Testimonial:

"It was a pleasure to work with your firm, and I really appreciated how professional and supportive everyone was.”


On February 23rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Engineer in the Field of Chemical Engineering (Approval Notice).


General Field: Chemical Engineering

Position at the Time of Case Filing: Engineer

Country of Origin: China

State of Residence at the Time of Filing: California

Approval Notice Date: February 23rd, 2026

Processing Time: 1 month, 25 days (Premium Processing Upgrade Requested)


Case Summary:  

Client Background and Proposed Endeavor The client holds a Ph.D. in chemical engineering and is currently employed as a software engineer in the U.S. life sciences industry. As an expert in chemical engineering, the client’s proposed endeavor is to continue establishing robust computational algorithms and analysis pipelines for quantifying single-molecule dynamics in live-cell imaging data in order to improve the accuracy and efficiency of drug discovery and biomedical applications.

In the petition, we presented the client’s work as a practical bridge between advanced microscopy and computational analysis. Rather than treating single-molecule imaging as a niche topic, we explained how reliable, scalable quantification of molecular motion and interactions can strengthen screening workflows and reduce trial-and-error in early-stage therapeutic development.

National Significance of the Research We emphasized that the proposed endeavor has clear substantial merit and national importance because faster and more accurate molecular analytics can support safer, more effective biomedical innovation. The petition framed the national benefit around the client’s focus on building reusable computational tools that integrate with experimental imaging workflows, enabling more efficient tracking, diffusion analysis, and high-resolution characterization of molecular behavior in live cells.

We also highlighted that the client’s planned work is designed to generate broadly applicable methods that can support multiple stakeholders in biomedical research and development, rather than being limited to a single narrow application.

Impressive Credentials and Achievements To demonstrate that the client is well-positioned to advance the endeavor, we documented objective evidence of productivity and independent research uptake, while explaining how an adjudicator would likely interpret these metrics:

  • Publications: 4 peer-reviewed journal articles (including 2 first-authored)
  • Citations: 27 citations to the client’s published work
  • Competitive support: evidence of major funding sources supporting work aligned with the client’s research direction, including the Welch Foundation and the National Science Foundation
We did not present the numbers as automatically sufficient. Instead, we framed the citation record as evidence of independent reliance, meaning other researchers found the client’s methods and findings useful enough to reference and build upon. We also emphasized that the client’s publication record supports a cohesive technical narrative, including work that advances imaging-based characterization of molecular transport and enables computational approaches for higher-throughput, higher-precision single-molecule analysis.

Expert Endorsements The petition included 2 letters of recommendation from experts familiar with the client’s work. These letters helped translate specialized computational and imaging contributions into clear significance and corroborated the client’s ability to continue advancing the proposed endeavor in the United States. One expert stated that: “Therefore, it is critical that she be permitted to continue her research.”

Case Outcome USCIS approved the client’s I-140 EB-2 National Interest Waiver petition. This outcome reflects a well-structured presentation of substantial merit and national importance, along with a credible showing that the client is well-positioned to continue developing computational tools that improve the efficiency and accuracy of drug discovery and biomedical applications.